Amenorrhea - PowerPoint PPT Presentation

1 / 13
About This Presentation
Title:

Amenorrhea

Description:

Amenorrhea Darren Farley, M.D. Department of Obstetrics and Gynecology UKSM-Wichita Definitions and Epidemiology Primary amenorrhea absence of normal menstruation in ... – PowerPoint PPT presentation

Number of Views:430
Avg rating:3.0/5.0
Slides: 14
Provided by: wichitaKu
Learn more at: https://www.kumc.edu
Category:
Tags: amenorrhea

less

Transcript and Presenter's Notes

Title: Amenorrhea


1
Amenorrhea
  • Darren Farley, M.D.
  • Department of Obstetrics and Gynecology
  • UKSM-Wichita

2
Definitions and Epidemiology
  • Primary amenorrhea
  • absence of normal menstruation in a patient
    without previously established cycles
  • no periods by age 14 with no secondary sex
    changes
  • absence of menarche by age 16 regardless of
    secondary sex changes
  • no periods by 2 years after the start of
    secondary sex changes
  • lt 0.1-2.5 of reproductive age women

3
Definitions and Epidemiology
  • Secondary amenorrhea
  • absence of menses for 3 cycle lengths in
    oligomenorrhea, or for 6 months after having
    regular menses
  • 1-5 of the population

4
Clinical Presentation
  • History
  • milestones, development, diet, exercise, wt
    change
  • drug use (antipsychotics, hormones, narcs,
    anti-HTNs
  • systemic disease (hypothyroidism, adrenal
    insuff., GH excess)
  • past surgery, glactorrhea, hirsutism
  • gyn/ob hx (hemorrhage, DC, infection)
  • genetic history

5
Clinical Presentation
  • Physical
  • ht, wt, vitals
  • signs of thyroid dz (protuberant eyes, enlarged
    gland, puffy face, heat/cold intolerance)
  • secondary sex changes
  • thelarche (breast devel) avg. age 10.8 yrs
    indication of estrogen exposure
  • adrenarche (pubic/axillary hair development)
    avg. age 11 and indicates ovarian and adrenal
    androgen production and end organ response
  • decreased breast size or vaginal dryness
    indication decreasing estrogen exposure (or
    increasing androgens)
  • presence of a cervix (confirms presence of a
    uterus)

6
Etiology
  • Primary amenorrhea
  • gonadal failure is most common cause
  • uterovaginal agenesis is second most common cause
  • Anorexia nervosa is the most common cause of
    amenorrhea overall in teens
  • Secondary amenorrhea
  • pregnancy is most common cause
  • 49-62 have hypothalamic disorders, including PCO
  • 7-16 have pituitary disorders
  • 10 have ovarian disorders
  • 7 have Ashermans syndrome

7
DDx and Tx in Primary Amenorrhea2nd sex changes
absent, cervix present
  • 50 of patients
  • primary ovarian disorders
  • Turners sd pure gonadal dysgenesis chromosomal
    mosaics structural abnormalities of the sex
    chromosomes
  • CNS, hypothalamic, or pituitary failure
  • anatomic lesions Kallmans sd anorexia nervosa
    or bulimia exercise induced constitutional
    delay hyperprolactinemia
  • Endocrinopathies (17 alpha hydroxylase deficiency)

8
DDx and Tx in Primary Amenorrhea2nd sex changes
absent, cervix present
  • Work up includes measuring FSH
  • if gt40 and less than 30y/o
  • do karyotype
  • if Y chromosome exists, excise gonads
  • if 46XX, r/o 17a-hydroxylase deficiency
  • replace estrogen/progesterone, and if
    17a-hydroxylase deficient, replace steroids also
  • if low, then a problem with the CNS,
    hypothalamic, or pituitary exists
  • measure serum prolactin
  • consider CT
  • no karyotype needed (all are 46XX)
  • replace estrogen/progesterone
  • consider GH
  • fertility requires assistance

9
DDx and Tx in Primary Amenorrhea2nd sex changes
present, cervix present
  • May present w/ primary or secondary amenorrhea
  • 1/3 of pts with primary amenorrhea have breasts
    and a uterus, 1/4 of these have
    hyperprolactinemia
  • CNS or hypothalamic causes
  • anatomic lesions (can appear with or without
    secondary sex changes
  • drugs affecting prolactin levels (stimulators and
    inhibitors)
  • stress, exercise, and eating disorders
  • PCOS
  • functional hypothalamic amenorrhea
  • Pituitary causes
  • Ovarian causes (elevated gonadotropin and low
    estrogen)
  • radiation and chemo premature ovarian failure
    ovarian resistance sd PCOS infection vascular
    injury cystetomy
  • Uterine causes (only group in this category who
    will show normal endocrine findings

10
DDx and Tx in Primary Amenorrhea2nd sex changes
present, cervix present
  • Work up
  • r/o pregnancy
  • r/o hyperprolactinemia
  • if prolactin level elevated, evaluate thyroid
    function
  • measure FSH and LH
  • measure 17a-hydroxylase progesterone and
    progesterone
  • do a progesterone challenge test
  • Treatment
  • dopamine agonist therapy
  • combination OCP therapy
  • estrogen replacement

11
DDx and Tx in Primary Amenorrhea2nd sex changes
present, cervix absent
  • androgen insensitivity (testicular feminization
    sd)
  • mullerian anomalies or agenesis
  • work up
  • karyotype and testosterone level
  • if nl body hair and female testosterone levels,
    uterine agenesis is present and pt is sterile
  • karyotype is to r/o male pseudohermaphrodism
  • IVP should be done to r/o renal anomalies
  • may need reconstructive surgery
  • pts with AI are usually raised as girls (XY)
  • remove gonads after breast development and
    epiphyseal closure
  • replace estrogen

12
DDx and Tx in Primary Amenorrhea2nd sex changes
absent, cervix absent
  • lt1 of primary amenorrhea
  • pts are 46XY, but have abnormality in
    testosterone synthesis
  • mullerian inhibiting factor causes internal
    female organs to regress
  • DDx
  • 17a-hydroxylase deficiency
  • 17,20 desmolase deficiency
  • agonadism
  • Lab elevated gonadotropins and low-normal
    female testosterone levels
  • Tx remove testicles and replace estrogen no
    need for progesterone

13
Secondary Amenorrhea
  • Differential
  • similar to that of primary amenorrhea with cervix
    and secondary sex changes present
  • Work up
  • r/o pregnancy
  • r/o hyperprolactinemia
  • if prolactin level elevated, evaluate thyroid
    function
  • measure FSH and LH
  • measure 17a-hydroxylase progesterone and
    progesterone
  • do a progesterone challenge test
  • Treatment
  • dopamine agonist therapy
  • combination OCP therapy
  • estrogen replacement
Write a Comment
User Comments (0)
About PowerShow.com